Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Medullary thyroid carcinoma: The third most common thyroid cancer reviewed.

Stamatakos M, Paraskeva P, Stefanaki C, Katsaronis P, Lazaris A, Safioleas K, Kontzoglou K.

Oncol Lett. 2011 Jan;2(1):49-53. Epub 2010 Nov 23.

2.

Surgical approach to the management of medullary thyroid cancer: when is lymph node dissection needed?

Stamatakos M, Paraskeva P, Katsaronis P, Tasiopoulou G, Kontzoglou K.

Oncology. 2013;84(6):350-5. doi: 10.1159/000351148. Epub 2013 May 14. Review.

PMID:
23689063
3.

New presentation of familial medullary thyroid carcinoma in 87-year-old patient with high-risk RET proto-oncogene codon 620 mutation.

Jaggard MK, MacRae C, Ifeacho S, Robinson S, Tolley NS.

J Laryngol Otol. 2009 Jul;123(7):796-800. doi: 10.1017/S0022215108003472. Epub 2008 Sep 4. Review.

PMID:
18771606
4.

Medullary thyroid carcinoma--update and present management controversies.

Al-Rawi M, Wheeler MH.

Ann R Coll Surg Engl. 2006 Sep;88(5):433-8. Review.

5.

Current approaches to medullary thyroid carcinoma, sporadic and familial.

Fialkowski EA, Moley JF.

J Surg Oncol. 2006 Dec 15;94(8):737-47. Review.

PMID:
17131404
6.
7.

Sporadic medullary thyroid carcinoma: clinical data from a university hospital.

Correia-Deur JE, Toledo RA, Imazawa AT, Lourenço DM Jr, Ezabella MC, Tavares MR, Toledo SP.

Clinics (Sao Paulo). 2009 May;64(5):379-86.

8.

Diagnosis and management of medullary thyroid carcinoma.

Massoll N, Mazzaferri EL.

Clin Lab Med. 2004 Mar;24(1):49-83. Review.

PMID:
15157557
9.

RET codon 609 mutations: a contribution for better clinical managing.

Mian C, Sartorato P, Barollo S, Zane M, Opocher G.

Clinics (Sao Paulo). 2012;67 Suppl 1:33-6. Review.

10.

Preventive thyroidectomy in patients with hereditary medullary thyroid carcinoma found heterozygote for mutant RET proto-oncogene.

Konstantinou E, Sapsakos Mariolis T, Fotis T, Mitsos A, Restos S, Mamoura K, Soultati A, Elefsiniotis I, Kapellakis G.

Pediatr Endocrinol Rev. 2010 Dec;8(2):108-13. Review. Erratum in: Pediatr Endocrinol Rev. 2011 Dec;9(2):608. Evangelos, Konstantinou [corrected to Konstantinou, Evangelos]; Theodoros, Mariolis S [corrected to Sapsakos Mariolis, Theodoros]; Theofanis, Fotis [corrected to Fotis, Theofanis]; Aristotelis, Mitsos [corrected to Mitsos, Aristotelis]; Stilianos, Restos [corrected to Restos, Stylianos]; Konstantinia, Mamoura [corrected to Mamoura, Konstantina]; Aspasia, Soultati [corrected to Soultati, Aspasia]; Ioannis, Elefsiniotis [corrected to Elefsiniotis, Ioannis]; George, Kapellakis [corrected to Kapellakis, George].

PMID:
21150841
11.

Epidemiology and Clinical Presentation of Medullary Thyroid Carcinoma.

Raue F, Frank-Raue K.

Recent Results Cancer Res. 2015;204:61-90. doi: 10.1007/978-3-319-22542-5_3. Review.

PMID:
26494384
12.

Hypercalcitoninemia is not pathognomonic of medullary thyroid carcinoma.

Toledo SP, Lourenço DM Jr, Santos MA, Tavares MR, Toledo RA, Correia-Deur JE.

Clinics (Sao Paulo). 2009;64(7):699-706. doi: 10.1590/S1807-59322009000700015. Review.

13.

[Medullary thyroid carcinoma--current surgical aspects. Overview and retrospective analysis of 22 cases].

Todorov G, Petkov R, Lukanova Ts, Koĭchev A, Mladenovski V, Kŭtev N, Iarŭmov N.

Khirurgiia (Sofiia). 2006;(4-5):5-8. Bulgarian.

PMID:
18846693
14.
15.

Medullary thyroid carcinoma: long-term outcomes of surgical treatment.

Abraham DT, Low TH, Messina M, Jackson N, Gill A, Chou AS, Delbridge L, Learoyd D, Robinson BG, Sidhu S, Sywak M.

Ann Surg Oncol. 2011 Jan;18(1):219-25. doi: 10.1245/s10434-010-1339-y. Epub 2010 Sep 28.

PMID:
20878247
16.

Management of microcarcinomas (papillary and medullary) of the thyroid.

Wu LS, Milan SA.

Curr Opin Oncol. 2013 Jan;25(1):27-32. doi: 10.1097/CCO.0b013e328359feea. Review.

PMID:
23042124
17.

A single missense mutation in codon 918 of the RET proto-oncogene in sporadic medullary thyroid carcinomas.

Maeda S, Namba H, Takamura N, Tanigawa K, Takahashi M, Noguchi S, Nagataki S, Kanematsu T, Yamashita S.

Endocr J. 1995 Apr;42(2):245-50.

18.

Familial medullary thyroid carcinoma with noncysteine ret mutations: phenotype-genotype relationship in a large series of patients.

Niccoli-Sire P, Murat A, Rohmer V, Franc S, Chabrier G, Baldet L, Maes B, Savagner F, Giraud S, Bezieau S, Kottler ML, Morange S, Conte-Devolx B; French Calcitonin Tumors Group (GETC).

J Clin Endocrinol Metab. 2001 Aug;86(8):3746-53.

PMID:
11502806
19.

Early, Prophylactic Thyroidectomy in Hereditary Medullary Thyroid Carcinoma: A 26-year Monoinstitutional Experience.

Pelizzo MR, Torresan F, Boschin IM, Nacamulli D, Pennelli G, Barollo S, Rubello D, Mian C.

Am J Clin Oncol. 2015 Oct;38(5):508-13. doi: 10.1097/COC.0b013e3182a78fec.

PMID:
24064755
20.

RET genetic screening in patients with medullary thyroid cancer and their relatives: experience with 807 individuals at one center.

Elisei R, Romei C, Cosci B, Agate L, Bottici V, Molinaro E, Sculli M, Miccoli P, Basolo F, Grasso L, Pacini F, Pinchera A.

J Clin Endocrinol Metab. 2007 Dec;92(12):4725-9. Epub 2007 Sep 25.

PMID:
17895320

Supplemental Content

Support Center